Inozyme Pharma (INZY) Company Description: Inozyme Pharma Inc is a rare disease biopharmaceutical company developing novel therapeutics for the treatment of diseases of abnormal mineralization ...
Physiological extracellular matrix (ECM) calcification or mineralization is restricted to bones, teeth and the hypertrophic zone of growth plate cartilage. In contrast, pathological ECM ...
Inadequate levels of vitamin-K-dependent proteins are associated with abnormal mineralization of bone and cartilage in animal models, indicating important roles for this vitamin in regulation of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback